PHARMSTANDARD INTERNATIONAL
PHARMSTANDARD INTERNATIONAL
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-12-11 | OncoTartis | Pharmstandard International investment in Venture Round - OncoTartis | 6 M USD |
| 2015-07-16 | Protagonist Therapeutics | Pharmstandard International investment in Series C - Protagonist Therapeutics | 40 M USD |
| 2013-11-20 | Argos Therapeutics | Pharmstandard International investment in Series E - Argos Therapeutics | 17.5 M USD |
More informations about "Pharmstandard International"
Pharmstandard - Wikipedia
Pharmstandard was established in 2003 as a result of a merger. In May 2007 the company raised $880 million in an IPO, valuing the company at $2.2 billion. Roman Abramovich owned a 17% stake in the company until March 2008. In 2013 the company announced plans to buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard shares to fall 25%. See details»
Pharmstandard International - Crunchbase
Pharmstandard International. Corporate Venture Capital pharmstd.lu ; 129,739; Highlights. Investments 3. Diversity Investments 1. obfuscated. Exits . Unlock for free . Similar Companies …See details»
Group Profile - the official website Pharmstandard
The underlying principles of Pharmstandard social policy have been adjusted for the Russian National Policy of medicine procurement, stipulating substitution of expensive imported …See details»
Pharmstandard International S.A. - Société anonyme
Pharmstandard International S.A. – is a company with the main focus on venture investments in innovative medicine with strong potential at global markets and in Russia. The company was …See details»
Pharmstandard International - Investments, Portfolio & Company …
Pharmstandard International 's most notable exits include Protagonist Therapeutics and Argos Therapeutics. Which industries has this organization had the most exits in? Show . Protagonist …See details»
Pharmstandard - Crunchbase Company Profile & Funding
Pharmstandard is a pharmaceutical company that develops and manufactures modern pharmaceutical products. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... 2,738 Number of Organizations • $642.5B Total …See details»
For the sake - Pharmstandard
CONTENTS Pharmstandard Today 1.1 CEO Statement 6 1.2 Performance Highlights 8 1.3 Milestone Events in 2015 9 1.4 Management Responsibility Statement 10 1.5 Company’s …See details»
Pharmstandard. Annual Report 2012 PhIloSОphy ARm foR stAndARd
Post transaction Pharmstandard-Leksredstva JSC held 2,589,750 ordinary shares or 6.85% of Pharmstandard OJSC share capital. arbidol® data presented to WHo experts. Information on …See details»
Interview with Igor Krylov, CEO, Pharmstandard - PharmaBoardroom
Apr 9, 2011 Pharmstandard has been the leading company by sales in the commercial market for some time now. Arbidol®, as a brand, has been the best-selling product in Russia for the …See details»
Pharmstandard Company Profile - Office Locations, Competitors
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. It offers medicines for the treatment of cardiovascular …See details»
Pharmstandard Company Profile 2024: Valuation, …
Pharmstandard General Information Description. Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of cardiovascular diseases, diabetes mellitus, growth hormone …See details»
Farmstandart OAO : Pharmstandard OJSC announces that …
Dec 18, 2012 The main purpose of this Association is to coordinate business activities of its members - pharmaceutical manufacturers of the Eurasian Economic Community engaged in …See details»
Pharmstandard - Wikiwand
JSC Pharmstandard is a Russian multinational pharmaceutical company. It is headquartered in Dolgoprudny, Moscow Oblast.See details»
Abramovich to float Pharmstandard in London - Financial Times
Apr 11, 2007 Last year, Pharmstandard, which produces original pharmaceuticals as well as generic drugs, saw profits more than double to $72m on sales of $324m, up 50 pe r cent from …See details»
PHS-Tomskhimpharm JSC - the official website Pharmstandard
In 2017, he completed with distinction the professional retraining course at the National Research Tomsk State University for training managerial staff for national economy organizations of the …See details»
Summary Report of Preliminary Inspection Findings
Pharmstandard – Ufa Vitamin Plant and are not applicable to any other manufacturers of Gam - COVID-Vac or any batches of this product manufactured at any other manufacturing sites. The …See details»
Pharmstandard and Janssen Broaden Collaboration to Advance …
Jun 3, 2018 Pharmstandard’s state-of-the-art manufacturing facilities correspond to GMP standards and are certified by Russian and EU regulatory bodies. Under partnership …See details»
Summary Report of Preliminary Inspection Findings - Open Joint …
May 31, 2021 Summary Report of Preliminary Inspection Findings - Open Joint-Stock Company Pharmstandard - Ufa Vitamin Plant Ufa, Republic of Bashkortostan, Russia. News. 23 June, …See details»
U.S. Contributions to International Organizations, 2023 - United …
3 days ago Note: 508-compliant versions will be posted when complete. U.S. Contributions to International Organizations, 2023 [278 KB] Annex A-E, U.S. Contributions to International …See details»
Bridging interests - Pharmstandard
26 May 2016 Pharmstandard International, a wholly-owned subsidiary of Pharmstandard PJSC, acquired a 2.3% interest in Transmedics, the company that develops a portable ex-vivo organ …See details»